コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 BPD prevention and 47% routinely tested for Ureaplasma.
2 and cultured for Mycoplasma hominis and the ureaplasmas.
3 infections with mycoplasmas, especially the ureaplasmas (57%), were common and the organisms were th
4 energy production, with the one exception of Ureaplasma, a species that breaks down urea as its princ
9 gs and detection of myoplasmas, particularly ureaplasmas, and suggest the infections will remain comm
14 n additional patient with Reiter's syndrome, Ureaplasma DNA was also found in prostate biopsy tissue
15 One of the 61 specimens was positive from Ureaplasma DNA; this sample was from a patient with a cl
16 inflammatory mediators, we hypothesized that ureaplasma exposure would increase fetal responsiveness
21 lavage fluid (BAL) confirmed the presence of Ureaplasma in 100% of inoculated animals at 1 day, 60% a
22 he opinions of neonatologists on the role of Ureaplasma in bronchopulmonary dysplasia (BPD) developme
23 ollowing intra-amniotic infection (IAI) with Ureaplasma in pregnant rhesus monkeys and to explore con
24 no studies have determined the prevalence of ureaplasmas in moderately preterm and late-preterm (here
26 ocyte chemoattractant protein 1 at 7 days in Ureaplasma-infected mice but a trend toward increased TN
29 All published cases of clinically invasive Ureaplasma infections in the adult population are also r
31 ntratracheally with a mouse-adapted clinical Ureaplasma isolate (biovar 2) or sham inoculated with 10
33 ctions were detected with other mycoplasmas, ureaplasmas, other bacterial species, viruses, yeasts, o
34 ted to ascending intrauterine infection, and Ureaplasma parvum (UP) is commonly isolated in these cas
35 ated species Ureaplasma urealyticum (UU) and Ureaplasma parvum (UP) with NGU using 2 separate control
37 obes for the detection and discrimination of Ureaplasma parvum and U. urealyticum and their 14 serova
43 ypothesis that postnatal lung infection with Ureaplasma parvum is causally related to bronchopulmonar
47 niotic (IA) injections of media (control) or Ureaplasma parvum serovar 3 either 7 or 70 d before pret
49 ls were not associated with patients in whom Ureaplasma parvum was detected, in contrast to the detec
50 identification of Ureaplasma urealyticum and Ureaplasma parvum was performed on nucleic acids extract
51 oplasma hominis, Ureaplasma urealyticum, and Ureaplasma parvum with symptoms or disease in nonpregnan
54 gens undetected by provider-ordered testing (Ureaplasma parvum, Tropheryma whipplei, severe acute res
55 intra-amniotic inflammatory milieu preceding Ureaplasma parvum-induced preterm birth in mice, which w
57 We report an unusual case of spontaneous Ureaplasma pericardial effusion with tamponade associate
58 developed the first juvenile mouse model of Ureaplasma pneumonia and characterized the histopatholog
59 nly a tenuous association between individual Ureaplasma serovars and certain patient populations.
70 s specific and sensitive in the detection of Ureaplasma species in clinical specimens, and the serova
76 llicute infections, caused by Mycoplasma and Ureaplasma species, are serious complications after lung
79 e sought to characterize the epidemiology of Ureaplasma spp in candidates and donors and describe out
82 ant, 8.3% (n = 5) of recipients had positive Ureaplasma spp testing in urine pre-transplant, and 13.3
83 ant, 8.3% (n = 5) of recipients had positive Ureaplasma spp testing in urine pre-transplant, and 13.3
93 crobial activities of synthetic AMPs against Ureaplasma spp. were determined using a flow cytometry-b
96 clusion, AMPs have in vitro activity against Ureaplasma spp., and suppression of AMP expression might
97 ing Legionella pneumophila, Mycoplasma spp., Ureaplasma spp., Bacteroides spp., and Clostridioides di
101 European neonatal units, and differences in Ureaplasma treatment and prevention of BPD highlight the
102 ant phylogenetic relative of those bacteria, Ureaplasma urealyticum (parvum biovar), which is also a
104 ociation of the newly differentiated species Ureaplasma urealyticum (UU) and Ureaplasma parvum (UP) w
106 f 5 to 50 mug/ml) and lower activity against Ureaplasma urealyticum and U. canigenitalium (MIC of 200
107 lex, real-time PCR for the identification of Ureaplasma urealyticum and Ureaplasma parvum was perform
109 rachomatis (CT), Mycoplasma genitalium (MG), Ureaplasma urealyticum biovar 2 (UU-2), and Trichomonas
112 Mycoplasmas such as Mycoplasma hominis and Ureaplasma urealyticum have been isolated from the lungs
113 most common organism found in placentas was Ureaplasma urealyticum in 34% of the samples, with no ot
117 d thirteen Ureaplasma parvum isolates and 78 Ureaplasma urealyticum isolates were different from thei
120 coplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum using broth microdilution and aga
121 was proven to be bacterial contaminant since Ureaplasma urealyticum was subsequently demonstrated in
122 number of microbial genomes including 750-kb Ureaplasma urealyticum, 1.2-Mb Mycoplasma fermentans, 2.
123 oeae, C. trachomatis, Mycoplasma genitalium, Ureaplasma urealyticum, and herpes simplex virus 2.
124 ed the association of Mycoplasma genitalium, Ureaplasma urealyticum, and other potential pathogens wi
125 ely new species name for certain serovars of Ureaplasma urealyticum, and PCR is useful for species de
126 g an association between Mycoplasma hominis, Ureaplasma urealyticum, and Ureaplasma parvum with sympt
128 the second trimester than during the first--Ureaplasma urealyticum, Mycoplasma hominis, and Gardnere